Anna Vidal-Crespo, Vanina Rodriguez, Alba Matas-Cespedes, Eriong Lee, Alfredo Rivas-Delgado, Eva Giné, Alba Navarro, Sílvia Beà, Elias Campo, Armando López-Guillermo, Monica Lopez-Guerra, Gaël Roué, Dolors Colomer, and Patricia Pérez-Galán. 2017. “The Bruton Tyrosine Kinase Inhibitor CC-292 Shows Activity in Mantle Cell Lymphoma and Synergizes With Lenalidomide and NIK Inhibitors Depending on Nuclear Factor-κB Mutational Status”. Haematologica 102 (11). Pavia, Italy, e447-e451. https://doi.org/10.3324/haematol.2017.168930.